Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the month of September 2024, with a report date of September 16, 2024. The filing addresses a specific corporate governance event related to the Company's Business Combination Agreement rather than routine operational or financial reporting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a share issuance event triggered by stock price performance.
Material Changes
On September 13, 2024, the Company's ordinary shares achieved a dollar volume-weighted average price of $15.00 or greater for the twentieth trading day within a thirty trading-day period. This occurrence is designated as "Triggering Event II," following a similar event announced on August 15, 2024. As a result of this event:
- The Company is required to issue 5,000,000 Ordinary Shares ("Price Adjustment Shares") to existing shareholders on a pro-rata basis.
- 3,000,000 Ordinary Shares held by TWC Tech Holdings II, LLC have vested, and restrictions on these shares will be removed.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, operational outlook, or general risk factors. The primary contingency noted is the mandatory issuance of shares subject to applicable withholding taxes as defined in the Merger Agreement dated April 8, 2021.
Key Facts for Investor Verification
- Verify the exact number of Price Adjustment Shares to be issued to individual holdings based on pro-rata calculations.
- Confirm the timeline for the issuance of the 5,000,000 new shares and the removal of restrictions on the 3,000,000 vested shares.
- Assess the potential dilution impact of the new share issuance on existing shareholders.
- Review the specific withholding tax implications for shareholders receiving the Price Adjustment Shares.